14.12.2009 • News • GlaxoSmithKline (GSK)

GSK Signs $1 Billion Drug Deal with Chroma

Glaxosmithkline announced collaboration with Chroma Therapeutics to develop
macrophage-targeted compounds. Chroma has the potential to receive in excess of $1 billion in total milestone and option payments from GSK. Chroma will receive a significant upfront cash payment and GSK will invest in Chroma's Series D equity financing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Top-Feature